Skip to Content

Fulphila Injection Dosage

Generic name: PEGFILGRASTIM 6mg in 0.6mL
Dosage form: injection

Medically reviewed by Drugs.com. Last updated on May 1, 2019.

Patients with Cancer Receiving Myelosuppressive Chemotherapy

The recommended dosage of Fulphila is a single subcutaneous injection of 6 mg administered once per chemotherapy cycle. For dosing in pediatric patients weighing less than 45 kg, refer to Table 1. Do not administer Fulphila between 14 days before and 24 hours after administration of cytotoxic chemotherapy.

Administration

Fulphila is administered subcutaneously via a single-dose prefilled syringe for manual use.

Prior to use‚ remove the carton from the refrigerator and allow the Fulphila prefilled syringe to reach room temperature for a minimum of 30 minutes. Discard any prefilled syringe left at room temperature for greater than 72 hours.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer Fulphila if discoloration or particulates are observed.

Pediatric Patients weighing less than 45 kg

The Fulphila prefilled syringe is not designed to allow for direct administration of doses less than 0.6 mL (6 mg). The syringe does not bear graduation marks, which are necessary to accurately measure doses of Fulphila less than 0.6 mL (6 mg) for direct administration to patients. Thus, the direct administration to patients requiring dosing of less than 0.6 mL (6 mg) is not recommended due to the potential for dosing errors. Refer to Table 1.

Table 1. Dosing of Fulphila for pediatric patients weighing less than 45 kg
*
For pediatric patients weighing less than 10 kg, administer 0.1 mg/kg (0.01 mL/kg) of Fulphila.

Body Weight

Fulphila Dose

Volume to Administer

Less than 10 kg*

See below*

See below*

10 to 20 kg

1.5 mg

0.15 mL

21 to 30 kg

2.5 mg

0.25 mL

31 to 44 kg

4 mg

0.4 mL

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Related questions

Hide